ClinicalTrials.gg
CompletedNCT02247570Updated Jan 27, 2016

Vestibular Rehabilitation Strategies in PTSD Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries

An interventional study of Vestibular Rehabilitation in Post Traumatic Stress Disorder PTSD, sponsored by Carrick Institute for Graduate Studies. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2016-01-27.

Sponsored by Carrick Institute for Graduate Studies · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The specific aim of this proposed study is to compare the effectiveness of Vestibular Rehabilitation (VR) in patients with PTSD who have suffered combat related traumatic brain injuries in a randomized controlled trial in terms of PTSD symptom reduction.

Read the detailed description

The study has been approved by our Institutional IRB and conducted in accordance with the principles of the Declaration of Helsinki. The trial will be registered at Clinicaltrials.gov, a service of the U.S. National Institutes of Health. There is equipoise. This randomized controlled trial will compare the effectiveness of VR in in patients with PTSD who have suffered combat related traumatic brain injuries. A blinded investigator that will not be involved in the study will perform the randomization and allocation procedure.

We will accomplish the specific aim of our study by analyzing the difference in the Clinician Administered DSM-IV PTSD Scale (CAPS) scores between the two groups in our study as outcomes to compare the effectiveness of VR. The CAPS is considered to be the gold standard for diagnosing PTSD and assessing symptom severity. We expect differences in the outcomes between both treatments to be immediate and at follow-up over time, i.e. immediately after 3 months, 6 months and 12 months after cessation of a 2 week treatment period. The study design will include one pre-treatment assessment and our post-treatment assessments (at 3 months, 6 months and 12 months). Investigators who will be blinded for the allocated treatment will perform all assessments. The study will be performed at the department of Neurology of our Institutional Brain Center in Dallas, Texas. Patient recruitment will begin starting in September 2014.

02

Conditions studied

  • Post Traumatic Stress Disorder PTSD

Keywords

  • Vestibular Rehabilitation
  • PTSD
  • DSM-IV
03

In context

Combat Disorders

142 studies on the registry are indexed under Combat Disorders; 71 are open to participants now.

This study's enrollment of 75 is close to the median of 72 across 119 interventional studies indexed under Combat Disorders.

Browse Combat Disorders studies →

Lead sponsor

Carrick Institute for Graduate Studies is the lead sponsor of 17 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veterans with extended combat exposure, confirmed by DD-214 with combat medal and honorable discharge.
  • Ages 18-60.
  • Texas residents (Per funding agency).
  • Medical history of TBI/head injury which occurred through military service.
  • Previous medical diagnosis of PTSD or currently suffering from PTSD-like symptoms.
  • Have attempted at least two of the following therapies with no significant outcome, or intolerable adverse effects: Anti-psychotic therapy (eg. Seroquel), SSRI therapy (i.e. Fluoxitiene, Celexa, etc), Atypical antidepressant therapy (Wellbutrin), Cognitive Behavior Therapy, Desensitization/exposure therapy, another form of Psychotherapy ("Talk" therapy), EMDR, or any other recognized therapy indicated for PTSD.

Exclusion criteria

Exclusion Criteria:

  • Concurrent therapy, including concurrent psychotherapy or pharmaceutical therapy.
  • Currently addicted to alcohol or an illegal substance. If you have been through an inpatient program, you must have been released at least 90 days prior to treatment start date and have remained free from drugs and alcohol since the release from inpatient.
  • Threat of harm to self and/or others
  • Psychotic disorder that would prevent compliance (e.g. dissociative disorder, schizophrenia, history of catatonic states).
  • Physical condition that would prevent any part of the treatment from being conducted in a safe and complete manner.
  • Concussion within the last 30 days.
  • History of stroke.
  • Neurodegenerative disease.
  • History of brain surgery, which included the removal of brain tissue.
  • Previously convicted of a felony crime.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    Vestibular Rehabilitation

    Vestibular Rehabilitation

    Procedure: Vestibular Rehabilitation

Interventions

  • ProcedureVestibular Rehabilitation

    Stimulation of the vestibular system by off axis rotational therapy, gaze stabilization, eye movement strategies, balance training

06

What researchers measure

Primary outcomes

  1. Change in DSM-IV CAPS

    Neuropsychiatric evaluation using gold standard DSM-IV protocols

    Time frame: pre and post treatment and 3 months, 6 months and 1 year

Secondary outcomes

  1. Change in Computerized Dynamic Posturography

    Force plate measurement of center of pressure and limits of stability

    Time frame: pre and post treatment and 3 months, 6 months and 1 year

  2. Change in Saccadometry/VNG

    Measurement of visual fixation, saccades, pursuits and optokinetic responses

    Time frame: pre and post treatment and 3 months, 6 months and 1 year

  3. Change in ImPACT testing

    Validated neuropsychological computerized testing

    Time frame: pre and post treatment and 3 months, 6 months and 1 year

07

Study locations

1 site
  • Carrick Brain Centers
    Irving, Texas 75062, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02247570
Lead sponsor
Carrick Institute for Graduate Studies
Collaborators
Carrick Brain Centers
Responsible party
Frederick Carrick, PhD, FACCN (Principle Investigator, Carrick Institute for Graduate Studies) — Principal investigator
First posted
Sep 25, 2014
Start date
Sep 2014
Primary completion
Feb 2015
Completion
Feb 2015
Last update
Jan 27, 2016

Study contacts

Frederick R Carrick, PhD
principal investigator · Carrick Brain Centers

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion